|
Sargas C, Ayala R, Chillon MC, Larrayoz MJ, Carrillo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martinez-Cuadron D, Bergua J, Amigo ML, Martinez-Sanchez P, Tormo M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas MJ, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez JM, Sanz MA, Sanchez-Garcia J, Gomez-Casares MT, Perez-Simon JA, Calasanz MJ, Gonzalez-Diaz M, Martinez-Lopez J, Barragan E, Montesinos P. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project. Haematologica. 2021 Dec 1;106(12):3079-3089. doi: 10.3324/haematol.2020.263806. PubMed PMID: 33179471; PubMed Central PMCID: PMC8634186.
AÑO: 2021; IF: 11.047
|
33179471
|
Boluda B, Martinez-Cuadron D, Algarra L, Cano I, Sayas MJ, Acuna-Cruz E, Blanco A, Marco-Ayala J, DeLapuerta R, Diaz-Gonzalez A, Tormo M, Rodriguez-Veiga R, Garcia R, Pinana JL, Lopez-Pavia M, Barragan E, Amigo ML, Sargas C, Lopez A, Solana-Altabella A, Gil C, Megias-Vericat JE, Sanz MA, Montesinos P. Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients. Leuk Lymphoma. 2021 Nov;62(11):2727-2736. doi: 10.1080/10428194.2021.1938031. Epub 2021 Jun 14. PubMed PMID: 34121593.
AÑO: 2021; IF: 2.996
|
|
Paiva B, Vidriales MB, Sempere A, Tarin F, Colado E, Benavente C, Cedena MT, Sanchez J, Caballero-Velazquez T, Cordon L, Garces JJ, Simoes C, Martinez-Cuadron D, Bernal T, Botella C, Grille S, Serrano J, Rodriguez-Medina C, Algarra L, Alonso-Dominguez JM, Amigo ML, Barrios M, Garcia-Boyero R, Colorado M, Perez-Oteyza J, Perez-Encinas M, Costilla-Barriga L, Sayas MJ, Perez O, Gonzalez-Diaz M, Perez-Simon JA, Martinez-Lopez J, Sossa C, Orfao A, San Miguel JF, Sanz MA, Montesinos P; PETHEMA (Programa para el Estudio de la Terapeutica en Hemopatias Malignas) cooperative study group. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. Leukemia. 2021 Aug;35(8):2358-2370. doi: 10.1038/s41375-021-01126-3. Epub 2021 Feb 1. PubMed PMID: 33526859.
AÑO: 2021; IF: 12.883
|
|
Hurtado Lopez AM, Chen-Liang TH, Zurdo M, Carrillo-Tornel S, Panadero J, Salido EJ, Beltran V, Muina B, Amigo M, Navarro-Villamor N, Cifuentes R, Calabria I, Anton AI, Teruel R, Muro M, Vicente V, Jerez A. Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach. Oncoimmunology. 2020 Oct 1;9(1):1824642. doi: 10.1080/2162402X.2020.1824642. PubMed PMID: 33101773; PubMed Central PMCID: PMC7553508.
AÑO: 2020; IF: 8.11
|
|
Ribera JM, Garcia O, Chapchap EC, Gil C, Gonzalez-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martinez-Carballeira D, Mercadal S, Hernandez-Rivas JM, Vall-Llovera F, Genesca E, Cladera A, Novo A, Abella E, Garcia-Cadenas I, Monteserin C, Bermudez A, Piernas S, Montesinos P, Lopez JL, Garcia-Guinon A, Serrano A, Martinez MP, Olivares M, Lopez A, Serrano J; PETHEMA Group, Spanish Society of Hematology. Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy. Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):e513-e522. doi: 10.1016/j.clml.2020.03.011. Epub 2020 Apr 5. PubMed PMID: 32336676.
AÑO: 2020; IF: 3.231
|